Back to Search Start Over

Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase

Authors :
William S. Nicoll
Christian Doerig
Michael R. Hollingdale
John B. Sacci
Carlo Rodolfo
David E. Lanar
Mauro Piacentini
Giuseppina Di Giacomo
Zoe Holland
BMC, Ed.
U.S. Military Malaria Vaccine Program
Walter Reed Army Institute of Research-Division of Malaria Vaccine Development
Department of Microbiology and Immunology
University of Maryland School of Medicine
University of Maryland System-University of Maryland System
Department of Biology
Università degli Studi di Roma Tor Vergata [Roma]
Controle de la Proliferation Cellulaire Chez Plasmodium Falciparum
Institut National de la Santé et de la Recherche Médicale (INSERM)
Consultant to the USMMVP
Malaria Department
Source :
Malaria Journal, Malaria Journal, BioMed Central, 2011, 10 (1), pp.14. ⟨10.1186/1475-2875-10-14⟩, Malaria Journal, Vol 10, Iss 1, p 14 (2011)
Publication Year :
2010

Abstract

Background Plasmodium falciparum sporozoites injected by mosquitoes into the blood rapidly enter liver hepatocytes and undergo pre-erythrocytic developmental schizogony forming tens of thousands of merozoites per hepatocyte. Shortly after hepatocyte invasion, the parasite starts to produce Liver Stage Antigen-1 (LSA-1), which accumulates within the parasitophorous vacuole surrounding the mass of developing merozoites. The LSA-1 protein has been described as a flocculent mass, but its role in parasite development has not been determined. Methods Recombinant N-terminal, C-terminal or a construct containing both the N- and C- terminal regions flanking two 17 amino acid residue central repeat sequences (LSA-NRC) were subjected to in vitro modification by tissue transglutaminase-2 (TG2) to determine if cross-linking occurred. In addition, tissue sections of P. falciparum-infected human hepatocytes were probed with monoclonal antibodies to the isopeptide ε-(γ-glutamyl)lysine cross-bridge formed by TG2 enzymatic activity to determine if these antibodies co-localized with antibodies to LSA-1 in the growing liver schizonts. Results This study identified a substrate motif for (TG2) and a putative casein kinase 2 phosphorylation site within the central repeat region of LSA-1. The function of TG2 is the post-translational modification of proteins by the formation of a unique isopeptide ε-(γ-glutamyl)lysine cross-bridge between glutamine and lysine residues. When recombinant LSA-1 protein was crosslinked in vitro by purified TG2 in a calcium dependent reaction, a flocculent mass of protein was formed that was highly resistant to degradation. The cross-linking was not detectably affected by phosphorylation with plasmodial CK2 in vitro. Monoclonal antibodies specific to the very unique TG2 catalyzed ε- lysine cross-bridge co-localized with antibodies to LSA-1 in infected human hepatocytes providing visual evidence that LSA-1 was cross-linked in vivo. Conclusions While the role of LSA-1 is still unknown these results suggest that it becomes highly cross-linked which may aid in the protection of the parasite as it develops.

Details

ISSN :
14752875
Volume :
10
Database :
OpenAIRE
Journal :
Malaria journal
Accession number :
edsair.doi.dedup.....bb6acf544f55b04e49e0effa1a6f8631
Full Text :
https://doi.org/10.1186/1475-2875-10-14⟩